References
- Yeo W, Pang E, Liem GS, Suen JJS, Ng RYW, Yip CCH, et al. Menopausal symptoms in relationship to breast cancer-specific quality of life after adjuvant cytotoxic treatment in young breast cancer survivors. Health Qual Life Outcomes 2020; 18: 24. doi: 10.1186/s12955-020-1283-x
- Silvestris E, Dellino M, Cafforio P, Paradiso AV, Cormio G, D'Oronzo S. Breast cancer: an update on treatment-related infertility. J Cancer Res Clin Oncol 2020; 146: 647-57. doi: 10.1007/s00432-020-03136-7
- Felicetti F, Castiglione A, Biasin E, Fortunati N, Dionisi-Vici M, Matarazzo P, et al. Effects of treatments on gonadal function in long-term survivors of pediatric hematologic malignancies: a cohort study. Pediatr Blood Cancer 2020; 67: e28709. doi: 10.1002/pbc.28709
- Yeganeh L, Boyle JA, Gibson-Helm M, Teede H, Vincent AJ. Women's perspectives of early menopause: development of a word cloud. Climacteric 2020; 23: 417-20. doi: 10.1080/13697137.2020.1730318
- Delattre S, Segers I, Van Moer E, Drakopoulos P, Mateizel I, Enghels L, et al. Combining fertility preservation procedures to spread the eggs across different baskets: a feasibility study. Hum Reprod 2020; 35: 2524-36. doi: 10.1093/humrep/deaa193.
- Dinas KD. Fertility counseling and preservation for breast cancer patients. Adv Exp Med Biol 2020; 1252: 181-87. doi: 10.1007/978-3-030-41596-9_25
- Bénard J, Duros S, El Hachem H, Sonigo C, Sifer C, Grynberg M. Freezing oocytes or embryos after controlled ovarian hyperstimulation in cancer patients: the state of the art. Future Oncol 2016; 12: 1731-41. doi: 10.2217/fon-2016-0095
- de Pedro M, Otero B, Martín B. Fertility preservation and breast cancer: a review. Ecancer 2015; 9: 503. doi: 10.3332/ecancer.2015.503
- Kasum M, Beketić-Orešković L, Peddi PF, Orešković S, Johnson RH. Fertility after breast cancer treatment. Eur J Obstet Gynecol Reprod Biol 2014; 173: 13-8. doi: 10.1016/j.ejogrb.2013.11.009
- Peccatori FA, Pup LD, Salvagno F, Guido M, Sarno MA, Revelli A, et al. Fertility preservation methods in breast cancer. Breast Care 2012; 7: 197202. doi: 10.1159/000339671
- Redig AJ, Brannigan R, Stryker SJ, Woodruff TK, Jeruss JS. Incorporating fertility preservation into the care of young oncology patients. Cancer 2011; 117: 4-10. doi: 10.1002/cncr.25398
- Meirow D. Reproduction post-chemotherapy in young cancer patients. Mol Cell Endocrinol 2000; 169: 123-31. doi: 10.1016/s0303-7207(00)00365-8
- Specchia C, Baggiani A, Immediata V, Ronchetti C, Cesana A, Smeraldi A, et al. Oocyte cryopreservation in oncological patients: eighteen years’ experience of a tertiary care referral center. Front Endocrinol 2019; 10: 600. doi: 10.3389/fendo.2019.00600
- Gook DA, Edgar DH. Cryopreservation of female reproductive potential. Best Pract Res Clin Obstet Gynaecol 2019; 55: 23-36. doi: 10.1016/j.bpobgyn.2018.08.005
- Cobo A, García-Velasco J, Domingo J, Pellicer A, Remohí J. Elective and oncofertility preservation: factors related to IVF outcomes. Hum Reprod 2018; 33: 2222-31. doi: 10.1093/humrep/dey321
- Dolmans MM, Donnez J. Fertility preservation in women for medical and social reasons: oocytes vs ovarian tissue. Best Pract Res Clin Obstet Gynaecol 2020; 21: S1521-6934(20)30122-X. doi: 10.1016/j.bpobgyn.2020.06.011
- Khalili MA, Shahedi A, Ashourzadeh S, Nottola SA, Macchiarelli G, Palmerini MG. Vitrification of human immature oocytes before and after in vitro maturation: a review. J Assist Reprod Genet 2017; 34: 1413-26. doi: 10.1007/s10815-017-1005-4
- Ata B, Chian RC, Tan SL. Cryopreservation of oocytes and embryos for fertility preservation for female cancer patients. Best Pract Res Clin Obstet Gynaecol 2010; 24: 101-12. doi: 10.1016/j.bpobgyn.2009.11.007
- El Hachem H, Atallah D, Grynberg M. Fertility preservation in breast cancer patients. Future Oncol 2014; 10: 1767-77. doi: 10.2217/fon.14.55
- Muñoz E, Domingo J, De Castro G, Lorenzo I, García-Velasco JA, Bellver J, et al. Ovarian stimulation for oocyte vitrification does not modify disease-free survival and overall survival rates in patients with early breast cancer. Reprod Biomed Online 2019; 39: 860-67. doi: 10.1016/j.rbmo.2019.07.003
- Rodgers RJ. Fertility preservation in breast cancer patients. Minerva Ginecol 2019; 71: 196-206. doi: 10.23736/S0026-4784.19.04409-5
- Grynberg M, Poulain M, le Parco S, Sifer C, Fanchin R, Frydman N. Similar in vitro maturation rates of oocytes retrieved during the follicular or luteal phase offer flexible options for urgent fertility preservation in breast cancer patients. Hum Reprod 2016; 31: 623-9. doi: 10.1093/humrep/dev325
- Grynberg M, Mayeur Le Bras A, Hesters L, Gallot V, Frydman N. First birth achieved after fertility preservation using vitrification of in vitro matured oocytes in a woman with breast cancer. Ann Oncol 2020; 31: 541-42. doi: 10.1016/j.annonc.2020.01.005
- World Health Organisation. WHO laboratory manual for the examination and processing of human semen. Geneva: WHO Press; 2010.
- Stimpfel M, Vrtacnik-Bokal E, Virant-Klun I. No difference in mitochondrial distribution is observed in human oocytes after cryopreservation. Arch Gynecol Obstet 2017; 296: 373-81. doi: 10.1007/s00404-017-4428-3
- Virant-Klun I, Bauer C, Ståhlberg A, Kubista M, Skutella T. Human oocyte maturation in vitro is improved by co-culture with cumulus cells from mature oocytes. Reprod Biomed Online 2018; 36: 508-23. doi: 10.1016/j.rbmo.2018.01.011
- Stimpfel M, Verdenik I, Zorn B, Virant-Klun I. Magnetic-activated cell sorting of non-apoptotic spermatozoa improves the quality of embryos according to female age: a prospective sibling oocyte study. J Assist Reprod Genet 2018; 35: 1665-74. doi:10.1007/s10815-018-1242-1
- ESHRE Special Interest Group of Embryology and Alpha Scientists in Reproductive Medicine. The Vienna consensus: report of an expert meeting on the development of art laboratory performance indicators. Hum Reprod Open 2017; 2017: 1-17. doi: 10.1093/hropen/hox011
- Lefebvre T, Mirallié S, Leperlier F, Reignier A, Barrière P, Fréour T. Ovarian reserve and response to stimulation in women undergoing fertility preservation according to malignancy type. Reprod Biomed Online 2018; 37: 201-7. doi: 10.1016/j.rbmo.2018.04.047
- Nordan T, Thomas AM, Ginsburg ES, Wen PY, Dolinko AV, Bortoletto P. Fertility preservation outcomes in women with gliomas: a retrospective case-control study. J Neurooncol 2020; 147: 371-76. doi: 10.1007/s11060-020-03429-4
- Malacarne E, Devesa M, Martinez F, Rodriguez I, Coroleu B. COH outcomes in breast cancer patients for fertility preservation: a comparison with the expected response by age. J Assist Reprod Genet 2020; 37: 3069-76. doi: 10.1007/s10815-020-01944-x
- Grynberg M, Dagher Hayeck B, Papanikolaou EG, Sifer C, Sermondade N, Sonigo C. BRCA1/2 gene mutations do not affect the capacity of oocytes from breast cancer candidates for fertility preservation to mature in vitro. Hum Reprod 2019; 34: 374-79. doi: 10.1093/humrep/dey358
- Gunnala V, Fields J, Irani M, D'Angelo D, Xu K, Schattman G, et al. BRCA carriers have similar reproductive potential at baseline to noncarriers: comparisons in cancer and cancer-free cohorts undergoing fertility preservation. Fertil Steril 2019; 111: 363-71. doi: 10.1016/j.fertnstert.2018.10.014
- Moria A, Das M, Shehata F, Holzer H, Son WY, Tulandi T. Ovarian reserve and oocyte maturity in women with malignancy undergoing in vitro maturation treatment. Fertil Steril 2011; 95: 1621-3. doi: 10.1016/j.fertnstert.2010.12.041
- Volodarsky-Perel A, Cai E, Tulandi T, Son WY, Suarthana E, Buckett W. Influence of stage and grade of breast cancer on fertility preservation outcome in reproductive-aged women. Reprod Biomed Online 2020; 40: 215-22. doi: 10.1016/j.rbmo.2019.11.006
- Balayla J, Tulandi T, Buckett W, Holzer H, Steiner N, Shrem G, et al. Outcomes of ovarian stimulation and fertility preservation in breast cancer patients with different hormonal receptor profiles. J Assist Reprod Genet 2020; 37: 913-21. doi: 10.1007/s10815-020-01730-9
- Shalom-Paz E, Almog B, Shehata F, Huang J, Holzer H, Chian RC, et al. Fertility preservation for breast-cancer patients using IVM followed by oocyte or embryo vitrification. Reprod Biomed Online 2010; 21: 566-71. doi: 10.1016/j.rbmo.2010.05.003
- Liu Z, Liang G, Tan L, Su AN, Jiang W, Gong C. High-efficient screening method for identification of key genes in breast cancer through microarray and bioinformatics. Anticancer Res 2017; 37: 4329-35. doi: 10.21873/anticanres.11826
- Cohen Y, Tannus S, Volodarsky-Perel A, Son WY, Tulandi T, Buckett W. Added benefit of immature oocyte maturation for fertility preservation in women with malignancy. Reprod Sci 2020; 27: 2257-64. doi: 10.1007/s43032-020-00245-z
- Chatroudi MH, Khalili MA, Ashourzadeh S, Anbari F, Shahedi A, Safari S. Growth differentiation factor 9 and cumulus cell supplementation in in vitro maturation culture media enhances the viability of human blastocysts. Clin Exp Reprod Med 2019; 46: 166-72. doi: 10.5653/cerm.2019.00402
- Sacha CR, Kaser DJ, Farland LV, Srouji S, Missmer SA, Racowsky C. The effect of short-term exposure of cumulus-oocyte complexes to in vitro maturation medium on yield of mature oocytes and usable embryos in stimulated cycles. J Assist Reprod Genet 2018; 35: 841-49. doi: 10.1007/s10815-018-1155-z
- Pongsuthirak P, Songveeratham S, Vutyavanich T. Comparison of blastocyst and Sage media for in vitro maturation of human immature oocytes. Reprod Sci 2015; 22: 343-6. doi: 10.1177/1933719114542027
- Junk SM, Yeap D. Improved implantation and ongoing pregnancy rates after single-embryo transfer with an optimized protocol for in vitro oocyte maturation in women with polycystic ovaries and polycystic ovary syndrome. Fertil Steril 2012; 98: 888-92. doi: 10.1016/j.fertnstert.2012.06.055
- Oktay K, Buyuk E, Rodriguez-Wallberg KA, Sahin G. In vitro maturation improves oocyte or embryo cryopreservation outcome in breast cancer patients undergoing ovarian stimulation for fertility preservation. Reprod Biomed Online 2010; 20: 634-8. doi: 10.1016/j.rbmo.2010.01.012
- D'Hondt C, Vanhoeij M, Van Moer E, Segers I, Fontaine C, Tournaye H, et al. Fertility preservation does not delay the initiation of chemotherapy in breast cancer patients treated with adjuvant or neo-adjuvant chemotherapy. Breast Cancer Res Treat 2020; 184: 433-44. doi: 10.1007/s10549-020-05858-1
- Huang JY, Chian RC, Gilbert L, Fleiszer D, Holzer H, Dermitas E, et al. Retrieval of immature oocytes from unstimulated ovaries followed by in vitro maturation and vitrification: A novel strategy of fertility preservation for breast cancer patients. Am J Surg 2010; 200: 177-83. doi: 10.1016/j.amjsurg.2009.04.004
- Oktay K, Demirtas E, Son WY, Lostritto K, Chian RC, Tan SL. In vitro maturation of germinal vesicle oocytes recovered after premature luteinizing hormone surge: description of a novel approach to fertility preservation. Fertil Steril 2008; 89: 228.e19-22. doi: 10.1016/j.fertnstert.2007.02.028
- Marklund A, Eloranta S, Wikander I, Kitlinski ML, Lood M, Nedstrand E, et al. Efficacy and safety of controlled ovarian stimulation using GnRH antagonist protocols for emergency fertility preservation in young women with breast cancer-a prospective nationwide Swedish multicenter study. Hum Reprod 2020; 35: 929-38. doi: 10.1093/humrep/deaa029
- American Society for Reproductive Medicine. Fertility preservation in patients undergoing gonadotoxic therapy or gonadectomy: a committee opinion. Practice Committee of the American Society for Reproductive Medicine. Fertil Steril 2019; 112: 1022-33. doi: 10.1016/j.fertnstert.2019.09.013
- Rose BI, Brown SE. A review of the physiology behind letrozole applications in infertility: are current protocols optimal? J Assist Reprod Genet 2020; 37: 2093-104. doi: 10.1007/s10815-020-01892-6
- Santiquet NW, Greene AF, Becker J, Barfield JP, Schoolcraft WB, Krisher RL. A pre-in vitro maturation medium containing cumulus oocyte complex ligand-receptor signaling molecules maintains meiotic arrest, supports the cumulus oocyte complex and improves oocyte developmental competence. Mol Hum Reprod 2017; 23: 594-606. doi: 10.1093/molehr/gax032
- Walls ML, Hunter T, Ryan JP, Keelan JA, Nathan E, Hart RJ. In vitro maturation as an alternative to standard in vitro fertilization for patients diagnosed with polycystic ovaries: a comparative analysis of fresh, frozen and cumulative cycle outcomes. Hum Reprod 2015; 30: 88-96. doi: 10.1093/humrep/deu248
- Walls ML, Hart R, Keelan JA, Ryan JP. Structural and morphologic differences in human oocytes after in vitro maturation compared with standard in vitro fertilization. Fertil Steril 2016; 106: 1392-98. doi: 10.1016/j.fertnstert.2016.08.014
- Roesner S, Dietrich JE, Weigert J, Montag M, Toth B, Strowitzki T. Time-lapse imaging reveals differences in growth dynamics of embryos after in vitro maturation compared with conventional stimulation. Fertil Steril 2017; 107: 606-12. doi: 10.1016/j.fertnstert.2016.12.026
- Belva F, Roelants M, Vermaning S, Desmyttere S, De Schepper J, Bonduelle M, et al. Growth and other health outcomes of 2-year-old singletons born after IVM versus controlled ovarian stimulation in mothers with polycystic ovary syndrome. Hum Reprod Open 2020; 2020: hoz043. doi: 10.1093/hropen/hoz043
- Yu EJ, Yoon TK, Lee WS, Park EA, Heo JY, Ko YK, et al. Obstetrical, neonatal, and long-term outcomes of children conceived from in vitro matured oo-cytes. Fertil Steril 2019; 112: 691-99. doi: 10.1016/j.fertnstert.2019.05.034
- Son WY, Henderson S, Cohen Y, Dahan M, Buckett W. Immature Oocyte for Fertility Preservation. Front Endocrinol 2019; 10: 464. doi: 10.3389/fendo.2019.00464
- Shirasawa H, Terada Y. In vitro maturation of human immature oocytes for fertility preservation and research material. Reprod Med Biol 2017; 16: 25867. doi: 10.1002/rmb2.12042